NCT00271297

Brief Summary

Background: The pelvic floor muscles (PFM) are located inside the pelvis, surrounding the urethra, vagina and rectum. They provide structural support for the pelvic organs. Dysfunctional PFM can lead to urine and fecal incontinence, pelvic organ prolapse (POP), sexual problems and chronic pain syndromes. POP increases with age, parity and weakness in the PFM. Symptoms associated with POP are backache, bladder, bowel and sexual dysfunction, and pelvic heaviness. Thus the condition is debilitating and can greatly affect the quality of life, interfering with day-to-day activities and reduce participation in physical activity. The aim of the project: As life expectancy increases, more women may experience POP. Hence it is important to prevent and treat the condition at an early stage. Despite being a common disorder among women, little research has been done on POP. The aim of this study is to evaluate the effect of pelvic floor muscle training (PFMT). PFMT is a non-invasive method with no adverse effects. If there is significant effect, the main goal is to incorporate this method in clinical practice among physiotherapists and medical doctors. If PFM training is effective, more emphasis of PFM training can be put into regular female fitness programs. The prevalence of POP increases with age. Method: This is a single blind randomised controlled trial to evaluate the effect of PFMT on POP. 100 women with POP will be randomised to either training or control group. The training programme will last for six months, training once a week with a physiotherapist in addition to a structured home training programme. A blinded case-control study will also be carried out. 50 women without POP will be matched for age and vaginal deliveries. Before starting the RCT study, a reproducibility study on perineal ultrasound will be carried out in 18 women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2005

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

December 29, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2005

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
Last Updated

September 21, 2009

Status Verified

September 1, 2009

Enrollment Period

3.2 years

First QC Date

December 29, 2005

Last Update Submit

September 18, 2009

Conditions

Keywords

pelvic floorexercise therapypreventionultrasonographyrisk factors

Outcome Measures

Primary Outcomes (12)

  • RCT:

  • Localisation of bladder neck, cervix and rectal ampulla at rest (translabial ultrasound)

  • Subjective symptoms score (Mouritsen and Larsen 2003, Tegerstedt et al in press, Avery et al 2004)

  • Ultrasound measurement of changes in muscle morphology: 1. thickness of levator ani

  • Size of levator hiatus

  • Levator activity during contraction, coughing and Valsava manoeuvre.

  • Case control study:

  • Comparison of background variables and risk factors

  • Presence of "Benign Hypermobility Joint Syndrome"

  • Measurement PFM strength

  • Reproducibility study:

  • Reproducibility of ultrasound examination of localisation and function of PFM and POP (same measurements as in the RCT)

Secondary Outcomes (3)

  • RCT study:

  • Independent variables (muscle function and strength)is vaginal palpation, visual observation of perineum, measurement of muscle strength with Camtech fibreoptic microtransducer connected to a vaginal balloon(Camtech AS, Sandvika, Norway)

  • * Training diary for registration of adherence

Interventions

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parous women in Oslo and Akershus
  • POP grade 1-3 on POP-Q.
  • Age 18-70

You may not qualify if:

  • Women with POP-Q grade 0 or 4 and women with cervix elongation
  • Women with other disease: radiating back pain, neurological disorders, previous pelvic cancer, psychiatric or other disorders that have an impact on ability to train or the condition (l.o. asthma). Women who is under treatment for cancer or uses muscle relaxants
  • Previous POP surgery
  • Women who wants to use pessary/ ring during the intervention period and three weeks prior to this
  • Pregnant or nursing women, or women planning to become pregnant in the intervention period
  • Women with untreated urinary tract infection
  • Women who do not understand Norwegian
  • Woman planning to be away more than 4 weeks of the intervention period
  • Women who cannot contract the PFM

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Norwegian School of Sport Sciences, department of Sports Medicine

Oslo, Oslo County, 0806, Norway

Location

Related Publications (1)

  • Hoff Braekken I, Majida M, Engh ME, Bo K. Morphological changes after pelvic floor muscle training measured by 3-dimensional ultrasonography: a randomized controlled trial. Obstet Gynecol. 2010 Feb;115(2 Pt 1):317-324. doi: 10.1097/AOG.0b013e3181cbd35f.

MeSH Terms

Conditions

Uterine ProlapseUrinary Bladder DiseasesCystoceleRectocele

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesPelvic Organ ProlapseProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrologic DiseasesMale Urogenital DiseasesRectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesHernia

Study Officials

  • Kari Bø, Prof, Dr.sci

    Norwegian School of Sport Sciences

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 29, 2005

First Posted

December 30, 2005

Study Start

December 1, 2005

Primary Completion

February 1, 2009

Study Completion

April 1, 2009

Last Updated

September 21, 2009

Record last verified: 2009-09

Locations